BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT), announced today that a poster describing the ongoing SNS01-T study in multiple myeloma will be presented at the 2012 Annual Meeting of the American Society of Clinical Oncology, June 1-5, 2012 in Chicago, Illinois. The abstract will be presented by Dr. John Lust, the principal investigator from the Mayo Clinic, Rochester, Minnesota.
